JP2013519717A5 - - Google Patents

Download PDF

Info

Publication number
JP2013519717A5
JP2013519717A5 JP2012553390A JP2012553390A JP2013519717A5 JP 2013519717 A5 JP2013519717 A5 JP 2013519717A5 JP 2012553390 A JP2012553390 A JP 2012553390A JP 2012553390 A JP2012553390 A JP 2012553390A JP 2013519717 A5 JP2013519717 A5 JP 2013519717A5
Authority
JP
Japan
Prior art keywords
seq
polypeptide
variant
composition
bir01i
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Granted
Application number
JP2012553390A
Other languages
English (en)
Japanese (ja)
Other versions
JP2013519717A (ja
JP5926198B2 (ja
Filing date
Publication date
Priority claimed from GBGB1002559.1A external-priority patent/GB201002559D0/en
Application filed filed Critical
Publication of JP2013519717A publication Critical patent/JP2013519717A/ja
Publication of JP2013519717A5 publication Critical patent/JP2013519717A5/ja
Application granted granted Critical
Publication of JP5926198B2 publication Critical patent/JP5926198B2/ja
Expired - Fee Related legal-status Critical Current
Anticipated expiration legal-status Critical

Links

JP2012553390A 2010-02-15 2011-02-15 カバノキアレルギーに対するワクチン用ペプチド Expired - Fee Related JP5926198B2 (ja)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
GBGB1002559.1A GB201002559D0 (en) 2010-02-15 2010-02-15 Birch peptides for vaccine
GB1002559.1 2010-02-15
PCT/GB2011/000206 WO2011098778A2 (en) 2010-02-15 2011-02-15 Peptides for vaccines against birch allergy

Related Child Applications (1)

Application Number Title Priority Date Filing Date
JP2016042511A Division JP2016166194A (ja) 2010-02-15 2016-03-04 カバノキアレルギーに対するワクチン用ペプチド

Publications (3)

Publication Number Publication Date
JP2013519717A JP2013519717A (ja) 2013-05-30
JP2013519717A5 true JP2013519717A5 (enExample) 2014-04-03
JP5926198B2 JP5926198B2 (ja) 2016-05-25

Family

ID=42110757

Family Applications (2)

Application Number Title Priority Date Filing Date
JP2012553390A Expired - Fee Related JP5926198B2 (ja) 2010-02-15 2011-02-15 カバノキアレルギーに対するワクチン用ペプチド
JP2016042511A Pending JP2016166194A (ja) 2010-02-15 2016-03-04 カバノキアレルギーに対するワクチン用ペプチド

Family Applications After (1)

Application Number Title Priority Date Filing Date
JP2016042511A Pending JP2016166194A (ja) 2010-02-15 2016-03-04 カバノキアレルギーに対するワクチン用ペプチド

Country Status (20)

Country Link
US (2) US9017689B2 (enExample)
EP (2) EP3056213A1 (enExample)
JP (2) JP5926198B2 (enExample)
KR (1) KR20120120965A (enExample)
CN (1) CN102762225B (enExample)
AU (1) AU2011214104B2 (enExample)
CA (2) CA3139588A1 (enExample)
DK (1) DK2536429T3 (enExample)
EA (1) EA201290792A1 (enExample)
ES (1) ES2573651T3 (enExample)
GB (2) GB201002559D0 (enExample)
HR (1) HRP20160481T1 (enExample)
HU (1) HUE029138T2 (enExample)
IL (1) IL221196A0 (enExample)
MX (1) MX2012009431A (enExample)
NZ (1) NZ602380A (enExample)
PL (1) PL2536429T3 (enExample)
SG (1) SG183198A1 (enExample)
SI (1) SI2536429T1 (enExample)
WO (1) WO2011098778A2 (enExample)

Families Citing this family (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB201002559D0 (en) * 2010-02-15 2010-03-31 Circassia Ltd Birch peptides for vaccine
JP2015509487A (ja) * 2012-02-07 2015-03-30 ラ ホーヤ インスティテュート フォー アレルギー アンド イムノロジーLa Jolla Institute For Allergy And Immunology アレルゲンタンパク質由来のエピトープ並びに免疫応答モジュレーションのための方法及び使用
GB201209862D0 (en) 2012-06-01 2012-07-18 Circassia Ltd Cladosporium peptides
GB201211586D0 (en) * 2012-06-29 2012-08-15 Circassia Ltd Japanese cedar peptides for preventing or treating allergy
US20150088644A1 (en) 2013-09-23 2015-03-26 Facebook, Inc., a Delaware corporation Predicting User Interactions With Objects Associated With Advertisements On An Online System
CN106699584B (zh) * 2016-12-30 2018-06-26 南京农业大学 一种利用花粉作为天然催化剂制备的γ-氨基丁酸及其制备方法和应用
NZ759513A (en) 2017-06-01 2022-01-28 Regeneron Pharma Human antibodies to bet v 1 and methods of use thereof
CN110175468B (zh) * 2019-05-05 2020-12-01 浙江工业大学 一种保留分布特征的姓名脱敏方法
CN115633666B (zh) * 2021-07-19 2025-11-18 四川大学华西医院 人源化双致敏动物模型和系统性过敏动物模型的构建方法及其应用

Family Cites Families (14)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5703055A (en) 1989-03-21 1997-12-30 Wisconsin Alumni Research Foundation Generation of antibodies through lipid mediated DNA delivery
US5399346A (en) 1989-06-14 1995-03-21 The United States Of America As Represented By The Department Of Health And Human Services Gene therapy
WO1994001560A1 (en) 1991-07-12 1994-01-20 Immulogic Pharmaceutical Corporation Allergenic proteins and peptides from japanese cedar pollen
US5968526A (en) 1994-04-14 1999-10-19 Immulogic Pharamaceutical Corporation T cell epitopes of the major allergens from Dermatophagoides (house dust mite)
WO1999034826A1 (en) 1998-01-09 1999-07-15 Circassia Limited Methods and compositions for desensitisation
FR2788698B1 (fr) 1999-01-27 2001-03-30 Commissariat Energie Atomique Peptides et proteines aptes a desensibiliser les sujets allergiques au venin d'abeille et compositions les contenant
ES2316632T3 (es) 2001-12-05 2009-04-16 Circassia Limited Metodos y sistemas inmunoterapeuticos.
PT1403280E (pt) 2002-09-27 2005-11-30 Biomay Prod & Handel Vacinas hipoalergenicas baseadas no alergenio ph1 p 7 de polen de capim timoteo
US7923209B2 (en) 2003-03-14 2011-04-12 Anergis, S.A. Allergen peptide fragments and use thereof
ES2425486T3 (es) 2007-05-09 2013-10-15 Circassia Limited Análisis de pronóstico para determinar la respuesta de células T a antígenos HLA y uso del mismo en el campo del trasplante de tejidos
GB0710529D0 (en) 2007-06-01 2007-07-11 Circassia Ltd Vaccine
SI2083856T1 (sl) * 2007-08-15 2011-02-28 Circassia Ltd Peptidi za desenzibilizacijo proti alergijam
US8821887B2 (en) 2008-08-15 2014-09-02 Circassia Limited T-cell antigen peptide from allergen for stimulation of IL-10 production
GB201002559D0 (en) * 2010-02-15 2010-03-31 Circassia Ltd Birch peptides for vaccine

Similar Documents

Publication Publication Date Title
JP2013519717A5 (enExample)
AU724333B2 (en) Immunomodulatory peptides of vespid antigen 5
JP5389326B2 (ja) アレルゲンペプチド断片およびその利用
CA2689260C (en) Vaccine peptide combinations against cat allergy
Rolland et al. Stylicins, a new family of antimicrobial peptides from the Pacific blue shrimp Litopenaeus stylirostris
JP7320947B2 (ja) 新規な免疫原性CD1d結合ペプチド
JP5788319B2 (ja) ブタクサアレルギーの治療用のAmba1ペプチド
CN101977929B (zh) 用于治疗变态反应的主要1类和2类螨变应原的低变应原性杂合蛋白
US20060024334A1 (en) Immunotherapeutic methods and systems
US8821887B2 (en) T-cell antigen peptide from allergen for stimulation of IL-10 production
KR20100068252A (ko) 백신용 펩티드
JP2020023561A (ja) 改良モジュール型抗原移送分子及び動物におけるその使用
JP2006520380A5 (enExample)
CN106132996B (zh) 经改良的模块化抗原转运分子及其用途
Tasiemski et al. Proenkephalin A-derived peptides in invertebrate innate immune processes
US10806776B2 (en) Method of treating fungal infection
Brigatte et al. Hyperalgesic and edematogenic effects of peptides isolated from the venoms of honeybee (Apis mellifera) and neotropical social wasps (Polybia paulista and Protonectarina sylveirae)
Stöcklin et al. Structural identification by mass spectrometry of a novel antimicrobial peptide from the venom of the solitary bee Osmia rufa (Hymenoptera: Megachilidae)
US11789019B2 (en) Peptide MHCII tetramers to detect endogenous calnexin specific CD4 T cells
EP1517916B1 (fr) Sphéniscines et peptides analogues antimicrobiens pour la conservation des aliments
Hithashree Molecular Studies on Prospecting Antimicrobial Peptides from Leaf Weaver Ant Oecophylla Smaragdina
WO2016062832A2 (en) Vaccine development against the poultry red mite dermanyssus gallinae
MX2011009862A (es) Oligopeptidos sinteticos diseñados a partir de cisteinproteasas de acaros y metodos para la produccion de anticuerpos policlonales igy para la deteccion de acaros intradomiciliarios.
Parthasarathi Evaluation of Cross-protective Efficacy of Multi-antigen Co-Immunization against Rhipicephalus microplus and Hyalomma anatolicum
Danneels et al. Hymenoptera venoms: toxicity, components, stability, and standardization